Technology and Innovation, and Globalization Continue to develop 2022 Interim Results Summary and Highlights: Total revenue in the first half of 2022 amounted.
Stable Revenue Growth and Recurring Income, Elevating the Revenue Contribution of New Products, and Accelerating International Layout Highlights: Revenue for.
2021 Annual Results Summary and Highlights: Total operating revenue for the year amounted to RMB161.29 billion, representing a year-on-year increase of 18%;.
The Proportion of Revenue from Innovative Products Continues to Increase Highlights: Revenue for the year ended December 31, 2021 was RMB39,005 million,.
Fosun Pharma Announces 2021 Interim Results prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.